IL83586A - Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them - Google Patents

Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them

Info

Publication number
IL83586A
IL83586A IL83586A IL8358687A IL83586A IL 83586 A IL83586 A IL 83586A IL 83586 A IL83586 A IL 83586A IL 8358687 A IL8358687 A IL 8358687A IL 83586 A IL83586 A IL 83586A
Authority
IL
Israel
Prior art keywords
hexahydroarylquinolizines
spirocondensed
peripheral
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL83586A
Other languages
English (en)
Other versions
IL83586A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL83586A0 publication Critical patent/IL83586A0/xx
Publication of IL83586A publication Critical patent/IL83586A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL83586A 1986-08-28 1987-08-19 Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them IL83586A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90148586A 1986-08-28 1986-08-28

Publications (2)

Publication Number Publication Date
IL83586A0 IL83586A0 (en) 1988-01-31
IL83586A true IL83586A (en) 1991-12-15

Family

ID=25414273

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83586A IL83586A (en) 1986-08-28 1987-08-19 Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them

Country Status (14)

Country Link
EP (1) EP0259092B1 (xx)
JP (1) JP2582799B2 (xx)
KR (1) KR880002869A (xx)
AT (1) ATE78482T1 (xx)
AU (1) AU597412B2 (xx)
CA (1) CA1288435C (xx)
DE (1) DE3780542T2 (xx)
DK (1) DK447387A (xx)
ES (1) ES2044944T3 (xx)
GR (1) GR3005537T3 (xx)
IL (1) IL83586A (xx)
NZ (1) NZ221485A (xx)
PT (1) PT85593B (xx)
ZA (1) ZA876400B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942235A (en) * 1989-03-16 1990-07-17 Merck & Co., Inc. Process for certain (2R-trans)hexahydroaroquinolizines
US5229387A (en) * 1991-09-20 1993-07-20 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6141745A (en) * 1998-04-30 2000-10-31 Advanced Micro Devices, Inc. Functional bit identifying a prefix byte via a particular state regardless of type of instruction
FI126838B (en) 2014-12-16 2017-06-15 Vetcare Oy Process for the preparation of spirocyclic substituted benzofuroquinolizines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435573A (en) * 1973-05-25 1976-05-12 Wyeth John & Brother Ltd Indoloquinolizines
GB2106909B (en) * 1981-10-07 1984-09-19 Wyeth John & Brother Ltd Benzoquinolizines
IE57014B1 (en) * 1983-03-25 1992-03-11 Wyeth John & Brother Ltd Benzoquinolizines
IL74147A (en) * 1984-02-02 1988-08-31 Merck & Co Inc 2-acylamino-hexahydro-arylquinolizines and salts thereof and pharmaceutical compositions containing them
NZ216283A (en) * 1985-06-03 1989-10-27 Merck & Co Inc Hexahydro arylquinolizine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
DE3780542T2 (de) 1993-01-07
AU7720587A (en) 1988-03-03
CA1288435C (en) 1991-09-03
ATE78482T1 (de) 1992-08-15
JP2582799B2 (ja) 1997-02-19
PT85593A (en) 1987-09-01
DK447387D0 (da) 1987-08-27
IL83586A0 (en) 1988-01-31
GR3005537T3 (xx) 1993-06-07
KR880002869A (ko) 1988-05-12
DE3780542D1 (en) 1992-08-27
NZ221485A (en) 1991-04-26
DK447387A (da) 1988-02-29
ES2044944T3 (es) 1994-01-16
JPS63139183A (ja) 1988-06-10
EP0259092A1 (en) 1988-03-09
EP0259092B1 (en) 1992-07-22
AU597412B2 (en) 1990-05-31
ZA876400B (en) 1988-02-25
PT85593B (pt) 1990-05-31

Similar Documents

Publication Publication Date Title
RU94027569A (ru) Органические соли n,n'-диацетилцистина, способ получения, фармацевтическая композиция, способы лечения
KR890002030A (ko) 메데토 미딘의 d 및 1 에난티오머, 그 분리 방법 및 이를 포함하는 제약학적 조성물
DE252290T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
HU9203383D0 (en) 2-amino-methyl-chromane derivatives and method for producing said compounds and pharmaceutical preparatives containing them
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
IL104006A (en) Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them
PL330207A1 (en) Aryl-substituted cyclic amines as selective ligands of d 3 dopamine
RU93004793A (ru) Производные хиназолина, способ их получения, фармацевтическая композиция на их основе
FR2531950B1 (fr) Derives d'amides d'acide o-amines, leur preparation, leur utilisation dans le traitement des affections du systeme nerveux central et des troubles cardiovasculaires, et compositions les contenant
IL83586A (en) Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them
DE68919252T2 (de) Tetrahydroisochinoline und Tetrahydrobenzazepine und Verfahren zur Herstellung.
IL104005A0 (en) Piperidylmethyl-substituted chroman derivatives,their preparation and pharmaceutical compositions containing them
ES8304976A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
NZ222045A (en) From diamides up to tetrapeptides for use as anticanvulsants
ES557149A0 (es) Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida.
IT1209276B (it) Composizione farmaceutica per la somministrazione orale del metilestere dell'acido 13a-etil-2,3,5,6,12,13,13a,13b-ottaidro-12-idrossi1h-indolo-[3,2,1-de] pirido [3,2,1-ij] [1,5] naftiridina -12-carbossilico
BE905718A (fr) Compositions pharmaceutiques contenant la 2-methyl-thiazolo[4,5-c]quinoleine et leur procede de preparation.
IT1198263B (it) Esteri dell'azoniaspironortropanolo,procedimento per la loro preparazione,mezzi farmaceutici che li contengono e impiego di esteri dell'azoniaspironortropanolo come spasmolitico,asmaterapeutico e broncolitico
MA19881A1 (fr) Procede de preparation de derives de spiro (2h-1,4-benzodioxepine-3 (5h) 4'-piperidine et -3'-pyrrolidine).
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
EP0202986A3 (en) Use of "naftidrofuryl" in the treatment of neuropathies
RU95114403A (ru) Применение ламотрижина в качестве лекарственного средства для лечения неврологических нарушений, вызванных травмами и способ получения лекарственного средства
EP0207514A3 (en) 1,4-dihydropyridine derivatives, process for preparing them, pharmaceutical composition and use

Legal Events

Date Code Title Description
RH Patent void